The policy change would affect artificial hearts and ventricular assist devices, which are used to treat patients with advanced heart failure. Currently, Medicare only covers these artificial heart devices when beneficiaries are enrolled in a clinical study.
Under the new policy, artificial hearts could be covered without being linked to a clinical study. Coverage determinations for artificial hearts would be made by local Medicare Administrative Contractors.
CMS said while a small number of Medicare patients receive artificial hearts, the proposed coverage expansion would treat end-stage heart disease without causing delays.
Read more here.
More articles on payers:
Fraudulent coding led CMS to overpay Cigna $1.4B, Justice Department says
Lawmakers to probe health insurer profits
5 payers that made $1B+ in Q2
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
